Nabriva Therapeutics AG
Nabriva Therapeutics AG (NBRV) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 346 transactions totaling $7.3M, demonstrating a bearish sentiment with -$4.9M in net insider flow. The most recent transaction on Jan 29, 2023 involved a transaction of 431 shares valued at $647.
NBRV Insider Activity Summary
Who Is Buying NBRV Stock?
No significant insider buying has been recorded for NBRV in the recent period.
Who Is Selling NBRV Stock?
No significant insider selling has been recorded for NBRV in the recent period.
Is Nabriva Therapeutics AG Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NBRV is bearish with an Insider Alignment Score of 17/100 and a net flow of -$4.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
NBRV Frequently Asked Questions
Understanding NBRV Insider Activity
Insider trading at Nabriva Therapeutics AG (NBRV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading NBRV stock, having executed 346 transactions in the past 90 days. The most active insider is Healthcare Investments (cayman) Ltd. Hbm (Executive), who has made 46 transactions totaling $6.0M.
Related Tools
Track Nabriva Therapeutics AG Insider Activity
Get notified when executives and directors at NBRV file new Form 4 transactions